IMPLEMENTING A COMPREHENSIVE CELLULAR THERAPY PROGRAM IN THE OUTPATIENT SETTING FOR BISPECIFIC T-CELL ENGAGERS (BITE): A COMMUNITY HOSPITAL SUCCESS STORY.
Significance & Background: Recently, several BiTE therapies were FDA approved for a variety of hematological and solid tumor malignancies. Community hospitals are uniquely positioned to deliver advanced cellular therapies in the outpatient setting, extending innovative treatments to a broader patien...
| Publicado en: | Oncology Nursing Forum Vol. 53; no. 2; pp. 27 - 29 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Oncology Nursing Society
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |